A detailed history of Yhb Investment Advisors, Inc. transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Yhb Investment Advisors, Inc. holds 46,450 shares of TMO stock, worth $27.6 Million. This represents 2.02% of its overall portfolio holdings.

Number of Shares
46,450
Previous 46,250 0.43%
Holding current value
$27.6 Million
Previous $28.6 Million 15.53%
% of portfolio
2.02%
Previous 2.41%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 22, 2025

BUY
$501.29 - $612.85 $100,258 - $122,570
200 Added 0.43%
46,450 $24.2 Million
Q3 2024

Oct 22, 2024

SELL
$531.86 - $624.21 $233,486 - $274,028
-439 Reduced 0.94%
46,250 $28.6 Million
Q2 2024

Aug 01, 2024

SELL
$541.52 - $599.02 $161,914 - $179,106
-299 Reduced 0.64%
46,689 $25.8 Million
Q1 2024

Aug 14, 2024

BUY
$528.82 - $599.43 $158,117 - $179,229
299 Added 0.64%
46,988 $27.3 Million
Q1 2024

Apr 26, 2024

SELL
$528.82 - $599.43 $456,371 - $517,308
-863 Reduced 1.8%
46,988 $27.3 Million
Q4 2023

Jan 29, 2024

SELL
$431.41 - $532.94 $1.21 Million - $1.5 Million
-2,808 Reduced 5.54%
47,851 $25.4 Million
Q3 2023

Oct 23, 2023

SELL
$498.29 - $574.41 $160,947 - $185,534
-323 Reduced 0.63%
50,659 $25.6 Million
Q2 2023

Aug 10, 2023

SELL
$508.46 - $591.13 $249,145 - $289,653
-490 Reduced 0.95%
50,982 $26.6 Million
Q1 2023

May 08, 2023

SELL
$535.0 - $604.82 $163,710 - $185,074
-306 Reduced 0.59%
51,472 $29.7 Million
Q4 2022

Jan 12, 2023

SELL
$484.71 - $571.37 $805,588 - $949,616
-1,662 Reduced 3.11%
51,778 $0
Q3 2022

Nov 03, 2022

SELL
$507.19 - $604.49 $103,973 - $123,920
-205 Reduced 0.38%
53,440 $27.1 Million
Q2 2022

Jul 14, 2022

SELL
$500.9 - $612.21 $209,376 - $255,903
-418 Reduced 0.77%
53,645 $29.1 Million
Q1 2022

Apr 14, 2022

SELL
$524.0 - $644.92 $966,780 - $1.19 Million
-1,845 Reduced 3.3%
54,063 $31.9 Million
Q4 2021

Jan 18, 2022

SELL
$569.0 - $667.24 $186,063 - $218,187
-327 Reduced 0.58%
55,908 $37.3 Million
Q3 2021

Oct 28, 2021

SELL
$509.53 - $609.78 $343,423 - $410,991
-674 Reduced 1.18%
56,235 $32.1 Million
Q2 2021

Jul 15, 2021

SELL
$441.0 - $508.24 $87,759 - $101,139
-199 Reduced 0.35%
56,909 $28.7 Million
Q1 2021

Apr 22, 2021

SELL
$439.85 - $518.83 $234,440 - $276,536
-533 Reduced 0.92%
57,108 $28.2 Million
Q4 2020

Jan 21, 2021

SELL
$435.06 - $527.66 $243,198 - $294,961
-559 Reduced 0.96%
57,641 $26.8 Million
Q3 2020

Nov 02, 2020

SELL
$359.77 - $441.52 $4.64 Million - $5.69 Million
-12,884 Reduced 18.13%
58,200 $25.7 Million
Q2 2020

Jul 20, 2020

SELL
$275.2 - $362.34 $300,518 - $395,675
-1,092 Reduced 1.51%
71,084 $25.8 Million
Q1 2020

Apr 16, 2020

SELL
$255.3 - $340.05 $191,985 - $255,717
-752 Reduced 1.03%
72,176 $20.5 Million
Q4 2019

Jan 27, 2020

SELL
$271.93 - $328.04 $723,333 - $872,586
-2,660 Reduced 3.52%
72,928 $23.7 Million
Q3 2019

Oct 15, 2019

BUY
$268.46 - $305.43 $401,079 - $456,312
1,494 Added 2.02%
75,588 $22 Million
Q2 2019

Jul 15, 2019

SELL
$257.51 - $295.55 $511,157 - $586,666
-1,985 Reduced 2.61%
74,094 $21.8 Million
Q1 2019

Apr 29, 2019

SELL
$212.17 - $273.72 $177,161 - $228,556
-835 Reduced 1.09%
76,079 $20.8 Million
Q4 2018

Jan 11, 2019

SELL
$208.47 - $251.98 $4.41 Million - $5.33 Million
-21,167 Reduced 21.58%
76,914 $17.2 Million
Q3 2018

Oct 29, 2018

SELL
$205.57 - $244.32 $290,264 - $344,979
-1,412 Reduced 1.42%
98,081 $23.9 Million
Q2 2018

Jul 09, 2018

BUY
$203.14 - $219.53 $79,021 - $85,397
389 Added 0.39%
99,493 $20.6 Million
Q1 2018

Apr 16, 2018

BUY
$192.98 - $224.11 $141,068 - $163,824
731 Added 0.74%
99,104 $20.5 Million
Q4 2017

Jan 16, 2018

BUY
$182.03 - $200.37 $36,406 - $40,074
200 Added 0.2%
98,373 $18.7 Million
Q3 2017

Nov 06, 2017

BUY
$171.74 - $194.04 $16.9 Million - $19 Million
98,173
98,173 $18.6 Million

Others Institutions Holding TMO

About THERMO FISHER SCIENTIFIC INC.


  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $233B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track This Portfolio

Track Yhb Investment Advisors, Inc. Portfolio

Follow Yhb Investment Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Yhb Investment Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Yhb Investment Advisors, Inc. with notifications on news.